Test Directory
| Test Code | ||
| INSU | ||
| Test Name | ||
| Insulin | ||
| CPT Codes | ||
| 83525 | ||
| Expected Turnaround Time | ||
| 1 - 3 days | ||
| Clinical Utility | ||
|
Can be used to evaluate insulin producing neoplasm (islet cell tumor, insulinoma) or pancreatic islet cell hyperplasia; work-up for hypoglycemia to evaluate insulin production in diabetes mellitus. Insulin-secreting tumors usually present with hypoglycemic symptoms and are diagnosed by a 72-hour prolonged fast. After 72 hours of fasting, an insulin concentration greater than 6 mU/L indicates an insulinoma. Factitious hypoglycemia from exogenous insulin shows increased insulin, but not proinsulin or C-peptide. |
||
| Specimen and Container Info | ||
|
Specimen Type: Serum Preferred Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Separator Minimum Acceptable Volume: 1.0 mL |
||
| Processing and Submission Instructions | ||
|
Separator tubes: Contains clot activator and gel for separating serum from cells, but not anticoagulant. Separate serum from cells as soon as the clot has formed (30 minutes). If specimen is centrifuged before clotting is complete, a fibrin clot will form on top of the cell. This may cause the gel barrier to not be intact and could cause improper separation of serum and cells, possibly affecting test results. |
||
| Patient Preparation | ||
| Fasting | ||
| Transport Instructions | ||
|
Transport to the laboratory refrigerated. |
||
| Stability Requirements | ||
|
||
| Methodology | ||
| Chemiluminescent Immunoassay | ||
| Reference Intervals | ||
| Performing Location | ||
| Roble Road Core Laboratory | ||
| Testing Schedule | ||
| Routine, daily | ||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.